The volume and complexity of clinical data are growing at a faster pace than the industry can manage. Pharma companies large and small are seeing significant increases in end-of-study timelines. The number one cause for end of study delays? External Vendor Data. With over 70% of clinical data now originating from outside EDC, the overwhelming amount of vendor data threatens to sink traditional data management tools and processes.
Find out how Pinnacle 21™ Data Exchange replaces the inefficient manual processes, spreadsheets, emails, study-specific programming efforts, and homegrown legacy solutions with could-based collaborative workflows.
Learn how this new solution streamlines the process of ingesting clinical trial data from external sources and significantly improves the process of acquiring and managing vendor data.